Endonovo Therapeutics Inc (ENDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The companys products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Its Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. Endonovo Therapeutics pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders such as acute concussions, post-concussion syndrome, ischemic heart disease, traumatic brain injury and multiple sclerosis. The companys Electroceuticals are electronic devices designed to affect biological systems to alleviate or mitigate symptomatology and pathology. Endonovo Therapeutics is headquartered in Woodland Hills, California, the US.

Endonovo Therapeutics Inc (ENDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11
Venture Financing 12
Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12
Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13
Endonovo Therapeutics Raises USD0.1 Million in Financing 14
Endonovo Therapeutics Raises Funds through Financing 15
Equity Offering 16
Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16
Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18
Debt Offering 19
Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19
Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20
Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21
Endonovo Therapeutics Inc - Key Competitors 22
Endonovo Therapeutics Inc - Key Employees 23
Endonovo Therapeutics Inc - Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Strategy And Business Planning 25
Jan 16, 2018: Endonovo Therapeutics Provides Corporate Update and 2018 Outlook 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List Of Tables


Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Endonovo Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11
Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12
Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13
Endonovo Therapeutics Raises USD0.1 Million in Financing 14
Endonovo Therapeutics Raises Funds through Financing 15
Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16
Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18
Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19
Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20
Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21
Endonovo Therapeutics Inc, Key Competitors 22
Endonovo Therapeutics Inc, Key Employees 23

List Of Figures


Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Endonovo Therapeutics Inc (ENDV) - Product Pipeline Analysis, 2019 Update

Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The companys products include Electroceutical Therapy a FDA-Cleared for the palliative treatment

USD 750 View Report

Endonovo Therapeutics Inc (ENDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The companys products include Electroceutical Therapy a FDA-Cleared for the palliative treatment

USD 250 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2019 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products

USD 750 View Report

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD)

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available